← Back to Clinical Trials
Recruiting NCT06338865

NCT06338865 Short Title: Standard vs. Lower Pressure Pneumoperitoneum

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06338865
Status Recruiting
Phase
Sponsor Cedars-Sinai Medical Center
Condition Laparoscopic Surgery
Study Type INTERVENTIONAL
Enrollment 294 participants
Start Date 2024-05-03
Primary Completion 2027-04

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Carbon dioxideBupivacaineOxycodone

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 294 participants in total. It began in 2024-05-03 with a primary completion date of 2027-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to investigate the effect of varying insufflation pressures on post-operative pain and adequacy of surgical field visualization among patients undergoing laparoscopic surgery with a minimally invasive gynecologic surgeon.

Eligibility Criteria

Inclusion Criteria: * Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * 18 years of age or older * Undergoing laparoscopic surgery at Cedars-Sinai Medical Center with a surgeon in the Minimally Invasive Gynecologic Surgery division. Exclusion Criteria: * Pregnancy * Urgent/non-scheduled surgery * Scheduled for planned or possible concomitant non-gynecologic surgery (e.g., urologic or colorectal procedure) * Baseline opioid use * Allergy or intolerance to bupivacaine (or amide class of anesthetics), oxycodone, acetaminophen, or ibuprofen * Planned post-operative admission

Contact & Investigator

Central Contact

Rebecca Schneyer, MD

✉ rebecca.schneyer@cshs.org

📞 914-391-2604

Principal Investigator

Matthew Siedhoff, MD

PRINCIPAL INVESTIGATOR

Cedars-Sinai Medical Center

Frequently Asked Questions

Who can join the NCT06338865 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Laparoscopic Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06338865 currently recruiting?

Yes, NCT06338865 is actively recruiting participants. Contact the research team at rebecca.schneyer@cshs.org for enrollment information.

Where is the NCT06338865 trial being conducted?

This trial is being conducted at Los Angeles, United States.

Who is sponsoring the NCT06338865 clinical trial?

NCT06338865 is sponsored by Cedars-Sinai Medical Center. The principal investigator is Matthew Siedhoff, MD at Cedars-Sinai Medical Center. The trial plans to enroll 294 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology